Literature DB >> 17671767

Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.

Hiroshi Wada1, Hiroaki Nagano, Takehiro Noda, Bazarragchaa Damdinsuren, Shigeru Marubashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Keizo Dono, Masato Sakon, Kenichi Wakasa, Morito Monden.   

Abstract

We report two cases of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) and lymph node (LN) metastases successfully treated by hepatic arterial infusion of 5-fluorouracil (5-FU) combined with systemic injection of interferon (IFN)-alpha following hepatic resection for the liver tumor. Complete remission was obtained. Case 1 was a 51-year-old man who had HCC in the right lobe of the liver with PVTT and multiple intrahepatic metastases. He also had abdominal and mediastinal LN metastases. Case 2 was a 53-year-old man who had diffuse-type HCC in the right lobe of the liver with PVTT and intrahepatic metastases. A chest computed tomography scan revealed lymph nodes enlarged to 1.0 cm from the mediastinum to the left supraclavicular space. Both patients underwent the hepatectomy to reduce the tumor volumes and remove the PVTT to relieve portal vein obstruction. Following the surgery, the patients underwent IFN-alpha/5-FU combination therapy. Three months after this combined therapy, tumor markers (both alpha-fetoprotein and protein induced by vitamin K absence or antagonist II) returned to the normal range and residual tumors in the liver disappeared. The patients are alive without any recurrence more than 1 year after initial treatment. IFN-alpha/5-FU combined therapy following hepatic resection is a promising modality for the treatment of advanced HCC with LN metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671767     DOI: 10.1007/s00535-007-2028-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


  22 in total

1.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

2.  Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy.

Authors:  S Okada; N Okazaki; H Nose; M Yoshimori; K Aoki
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

3.  Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches.

Authors:  Masato Sakon; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Akira Yamada; Sumio Kawata; Yasuharu Imai; Shohei Iijima; Morito Monden
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

4.  Expression of interferon alpha/beta receptor in human hepatocellular carcinoma.

Authors:  M Kondo; H Nagano; M Sakon; H Yamamoto; O Morimoto; I Arai; A Miyamoto; H Eguchi; K Dono; S Nakamori; K Umeshita; K Wakasa; Y Ohmoto; M Monden
Journal:  Int J Oncol       Date:  2000-07       Impact factor: 5.650

5.  Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.

Authors:  Hideo Ota; Hiroaki Nagano; Yuichiro Doki; Mitsugu Sekimoto; Motoi Kondo; Hiroshi Wada; Masato Nakamura; Takehiro Noda; Bazarragchaa Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshita; Shoji Nakamori; Kenichi Wakasa; Masato Sakon; Morito Monden
Journal:  Oncol Rep       Date:  2006-08       Impact factor: 3.906

6.  Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.

Authors:  Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sato; Ryosuke Tateishi; Takuma Teratani; Shuichiro Shiina; Masao Omata
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

7.  Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.

Authors:  T Okusaka; S Okada; H Ishii; H Nose; H Nagahama; H Nakasuka; K Ikeda; M Yoshimori
Journal:  Hepatogastroenterology       Date:  1997 Jan-Feb

8.  Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C.

Authors:  H Yatsuhashi; T Fujino; T Matsumoto; O Inoue; M Koga; M Yano
Journal:  J Hepatol       Date:  1999-06       Impact factor: 25.083

Review 9.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

10.  Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.

Authors:  Hiroaki Nagano; Masato Sakon; Hidetoshi Eguchi; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragcha Damdinsuren; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Keizo Dono; Koji Umeshit; Shoji Nakamori; Morito Monden
Journal:  Hepatogastroenterology       Date:  2007 Jan-Feb
View more
  3 in total

1.  Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon.

Authors:  Tomofumi Miura; Nobuaki Suzuki; Junichiro Nakamura; Satoshi Yamada; Tsutomu Miura; Masahiko Yanagi; Hiroyuki Usuda; Iwao Emura; Toru Takahashi
Journal:  World J Hepatol       Date:  2010-11-27

2.  Autologous formalin-fixed tumor vaccine suppressed re-recurrence of HCV-related hepatocellular carcinoma following 29 unsuccessful treatments with extensive conventional therapy: a case report.

Authors:  Toshio Inui; Tadao Ohno
Journal:  World J Surg Oncol       Date:  2012-07-12       Impact factor: 2.754

3.  Surgical treatment after hepatic arterial infusion chemotherapy for hepatocellular carcinoma extending into the right atrium.

Authors:  Shintaro Kurahashi; Tsuyoshi Sano; Seiji Natsume; Yoshiki Senda; Hidekazu Yamaura; Yoshitaka Inaba; Yasuhiro Shimizu
Journal:  Surg Case Rep       Date:  2015-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.